GLYCOVUE LTD

Company Registration Number:
11981346 (England and Wales)

Unaudited statutory accounts for the year ended 31 May 2025

Period of accounts

Start date: 1 June 2024

End date: 31 May 2025

GLYCOVUE LTD

Contents of the Financial Statements

for the Period Ended 31 May 2025

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

GLYCOVUE LTD

Directors' report period ended 31 May 2025

The directors present their report with the financial statements of the company for the period ended 31 May 2025

Principal activities of the company

The company’s principal activity is the development of health tech and related consultancy.

Political and charitable donations

The company made no political donations and no charitable donations during the year.



Directors

The director shown below has held office during the whole of the period from
1 June 2024 to 31 May 2025

Gita Khalili Moghaddam


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
30 May 2026

And signed on behalf of the board by:
Name: Gita Khalili Moghaddam
Status: Director

GLYCOVUE LTD

Profit And Loss Account

for the Period Ended 31 May 2025

2025 2024


£

£
Turnover: 0 0
Cost of sales: 0 0
Gross profit(or loss): 0 0
Distribution costs: 0 0
Administrative expenses: ( 5,255 ) ( 9,951 )
Other operating income: 0 0
Operating profit(or loss): (5,255) (9,951)
Interest receivable and similar income: 0 0
Interest payable and similar charges: 0 0
Profit(or loss) before tax: (5,255) (9,951)
Tax: 0 0
Profit(or loss) for the financial year: (5,255) (9,951)

GLYCOVUE LTD

Balance sheet

As at 31 May 2025

Notes 2025 2024


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 195 391
Investments:   0 0
Total fixed assets: 195 391
Current assets
Stocks:   0 0
Debtors:   0 0
Cash at bank and in hand: 4,629 8,331
Investments:   0 0
Total current assets: 4,629 8,331
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: 4 ( 1,592 ) ( 235 )
Net current assets (liabilities): 3,037 8,096
Total assets less current liabilities: 3,232 8,487
Creditors: amounts falling due after more than one year: 5 ( 20,000 ) ( 20,000 )
Provision for liabilities: 0 0
Accruals and deferred income: 0 0
Total net assets (liabilities): (16,768) (11,513)
Capital and reserves
Called up share capital: 1 1
Share premium account: 0 0
Other reserves: 0 0
Profit and loss account: (16,769 ) (11,514 )
Total Shareholders' funds: ( 16,768 ) (11,513)

The notes form part of these financial statements

GLYCOVUE LTD

Balance sheet statements

For the year ending 31 May 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 30 May 2026
and signed on behalf of the board by:

Name: Gita Khalili Moghaddam
Status: Director

The notes form part of these financial statements

GLYCOVUE LTD

Notes to the Financial Statements

for the Period Ended 31 May 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover represents amounts receivable for the provision of health tech development and related consultancy services, net of VAT and trade discounts. Turnover is recognised when the company has provided the relevant goods or services and the amount can be measured reliably. No turnover was recognised during the year.

    Tangible fixed assets depreciation policy

    Tangible fixed assets are stated at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided to write off the cost of tangible fixed assets over their estimated useful economic lives. Office equipment is depreciated on a straight-line basis over its expected useful life.

    Other accounting policies

    The financial statements have been prepared under the historical cost convention and in accordance with the provisions applicable to small companies under Section 1A of Financial Reporting Standard 102 and the Companies Act 2006. The accounts have been prepared on a going concern basis. The director has considered the company’s financial position and confirms that the company is able to continue to meet its liabilities as they fall due.

GLYCOVUE LTD

Notes to the Financial Statements

for the Period Ended 31 May 2025

  • 2. Employees

    2025 2024
    Average number of employees during the period 0 0

GLYCOVUE LTD

Notes to the Financial Statements

for the Period Ended 31 May 2025

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 June 2024 0 0 0 587 0 587
Additions 0 0 0 0 0 0
Disposals 0 0 0 0 0 0
Revaluations 0 0 0 0 0 0
Transfers 0 0 0 0 0 0
At 31 May 2025 0 0 0 587 0 587
Depreciation
At 1 June 2024 0 0 0 196 0 196
Charge for year 0 0 0 196 0 196
On disposals 0 0 0 0 0 0
Other adjustments 0 0 0 0 0 0
At 31 May 2025 0 0 0 392 0 392
Net book value
At 31 May 2025 0 0 0 195 0 195
At 31 May 2024 0 0 0 391 0 391

GLYCOVUE LTD

Notes to the Financial Statements

for the Period Ended 31 May 2025

4. Creditors: amounts falling due within one year note

2025 2024
£ £
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 0 0
Taxation and social security 0 0
Accruals and deferred income 235 235
Other creditors 1,357 0
Total 1,592 235

GLYCOVUE LTD

Notes to the Financial Statements

for the Period Ended 31 May 2025

5. Creditors: amounts falling due after more than one year note

2025 2024
£ £
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Other creditors 20,000 20,000
Total 20,000 20,000